Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cashflow Statement

COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹569 Cr₹868 Cr₹1,441 Cr₹1,382 Cr₹1,096 Cr
Adjustment ₹1,010 Cr₹1,472 Cr₹787 Cr₹645 Cr₹636 Cr
Changes In working Capital ₹-797 Cr₹-1,074 Cr₹-561 Cr₹-386 Cr₹127 Cr
Cash Flow after changes in Working Capital ₹782 Cr₹1,266 Cr₹1,667 Cr₹1,641 Cr₹1,859 Cr
Cash Flow from Operating Activities ₹-265 Cr₹625 Cr₹1,109 Cr₹1,131 Cr₹1,392 Cr
Cash Flow from Investing Activities ₹4,561 Cr₹-528 Cr₹-333 Cr₹-675 Cr₹-784 Cr
Cash Flow from Financing Activities ₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr₹-445 Cr
Net Cash Inflow / Outflow ₹389 Cr₹19 Cr₹255 Cr₹14 Cr₹164 Cr
Opening Cash & Cash Equivalents ₹1,443 Cr₹1,411 Cr₹1,138 Cr₹1,110 Cr₹936 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -₹0.67 Cr---
Cash & Cash Equivalent of Subsidiaries under liquidations ₹-192 Cr----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹18 Cr₹12 Cr₹18 Cr₹14 Cr₹9.76 Cr
Closing Cash & Cash Equivalent ₹1,658 Cr₹1,443 Cr₹1,411 Cr₹1,138 Cr₹1,110 Cr

Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,649.4 Cr -1.9% -9.5% 15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,187.0 Cr 0.6% -2.4% -7% Stock Analytics
DIVIS LABORATORIES ₹163,282.0 Cr -0.3% -7.6% 23% Stock Analytics
CIPLA ₹128,619.0 Cr 1.8% 8.1% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,712.0 Cr 0.9% 3.7% 8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,577.0 Cr 1% 2.4% -9.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.9%

-9.5%

15.6%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses